ResultsIQ

ResultsIQ › Latest results › Anlon Healthcare Limited

Anlon Healthcare Limited Q2 FY27 results deck summary

NSE: AHCL · BSE: 544497

Results deck of 30 Oct 2026, summarised by AI from the filing.

Anlon Healthcare Q2 FY27 revenue ₹10,561.0 lacs, up 102.3%, with CDMO commercial supplies targeted from Q3 FY27.

Key takeaways

  1. FY27 filings Management plans 3-5 new DMF filings and seven new APIs in FY27, and expects 5–7 products to commercialise in FY27.
  2. Gross margin Gross profit margin fell to 31.0% in Q2 FY27 from 36.9% in Q2 FY26, and EBITDA margin to 23.9% from 26.3%.

Original filing on BSE

Anlon Healthcare Limited Q2 FY27 results

As filed: Revenue ₹106 cr, EBITDA ₹25.2 cr, PAT ₹17.2 cr, EBITDA margin 23.9%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹106 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹31.0 cr (−6% year on year), EBITDA ₹7.5 cr (+24% year on year), PAT ₹4.8 cr (+20% year on year), EBITDA margin 24.1% (+590 bps). Score 53 of 100, In line with trend. EBITDA margin rose 590 bps year on year. Not enough history for a trend yet: scored on growth alone. Revenue fell 44% from last quarter. Share price after the results: +0.2% in 29 days (Nifty 500: +0.8%).
  • Q4 FY26: Revenue ₹55.4 cr, EBITDA ₹13.9 cr, PAT ₹9.8 cr, EBITDA margin 25.1%. Not scored. No result for the same quarter last year. Share price after the results: +14.3% in 27 days (Nifty 500: +0.6%).
  • Q3 FY26: Revenue ₹35.6 cr, EBITDA ₹12.3 cr, PAT ₹5.2 cr, EBITDA margin 34.7%. Not scored. No result for the same quarter last year. Share price after the results: +0.9% in 30 days (Nifty 500: −6.9%).
  • Q2 FY26: Revenue ₹52.0 cr, EBITDA ₹13.0 cr, PAT ₹9.0 cr, EBITDA margin 25.0%. Not scored. No result for the same quarter last year. Share price after the results: −0.8% in 30 days (Nifty 500: −0.2%).
  • Q1 FY26: Revenue ₹33.0 cr, EBITDA ₹6.0 cr, PAT ₹4.0 cr, EBITDA margin 18.2%. Not scored. No result for the same quarter last year.

Past price moves after results do not indicate future moves. Not a recommendation.

Anlon Healthcare Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.